The All India Institute of Medical Sciences (AIIMS) in Delhi will start recruitment for clinical trials tomorrow onwards for the children who are in the age group of 6-12 years, news agency ANI reported. It further said that clinical trial of children of 2-6 age group will start after that.

Earlier,the screening of children for trial of single-dose Covaxin, India’s first indigenously developed COVID-19 vaccine, among those aged between 12 to 18 started at the AIIMS in New Delhi on 7 June and is over.

The All India Institute of Medical Sciences (AIIMS) in Delhi will start recruitment for clinical trials tomorrow onwards for the children who are in the age group of 6-12 years, news agency ANI reported. It further said that clinical trial of children of 2-6 age group will start after that.

Earlier,the screening of children for trial of single-dose Covaxin, India’s first indigenously developed COVID-19 vaccine, among those aged between 12 to 18 started at the AIIMS in New Delhi on 7 June and is over.